Rentokil Initial (RKLIF) Return on Sales (2022 - 2025)
Rentokil Initial (RKLIF) reported Return on Sales of 0.0% for Q3 2025, down 150.06% quarter-over-quarter from 0.0% in Q4 2022.
Rentokil Initial (RKLIF) Return on Sales (2022 - 2025) Analysis & Trends
Rentokil Initial (RKLIF) has 2 years of Return on Sales data on file, last reported at 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 70.95 Bn | 70.77 Bn | 1.45 Bn | 0.00% |
| 2 | Copart | 29.43 Bn | 26.09 Bn | 1.08 Bn | 0.00% |
| 3 | Rb Global | 20.04 Bn | 19.85 Bn | 869.50 Mn | 0.00% |
| 4 | UL Solutions | 19.54 Bn | 19.30 Bn | 381.00 Mn | 0.00% |
| 5 | Global Payments | 18.52 Bn | 13.33 Bn | 1.70 Bn | -0.01% |
| 6 | Aramark | 14.28 Bn | 13.87 Bn | 426.35 Mn | 0.00% |
| 7 | Relx | 11.84 Bn | 11.60 Bn | - | - |
| 8 | Amentum Holdings | 5.58 Bn | 5.67 Bn | 345.00 Mn | 0.00% |
| 9 | Dolby Laboratories | 5.00 Bn | 4.42 Bn | 350.90 Mn | 0.00% |
| 10 | Rentokil Initial | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00% |
| Dec 31, 2022 | 0.00% |